The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities

Epidemiology and Infection

Volumn 132, Issue 3, 2004, Pages 409-415

  Hellard, M E ^a   Hocking, J S ^a   Crofts, N ^a  

^a BURNET INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; AUSTRALIA; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; HEALTH BEHAVIOR; HEPATITIS C VIRUS; HUMAN; INJECTION; INTRAVENOUS DRUG ABUSE; MALE; PREVALENCE; PRISON; PRISONER; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SAFETY; TATTOOING;

ADULT; ANTIBODIES, VIRAL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HEPATITIS C; HUMANS; MALE; PREVALENCE; PRISONERS; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; TATTOOING;

EID: 2642583195     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268803001882     Document Type: Article

References (26)

1. Hepatitis C Virus Epidemic in Australia 2002. In: Hepatitis C Virus Projections Working Group; 2002; Darlinghurst, NSW: Australian National Council on AIDS, Hepatitis C and Related Diseases: Hepatitis C Subcommittee, 2002.
2. Crofts N, Jolley D, Kaldor J, et al. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Commun Health 1997; 51: 692-697.
3. Crofts N, Aitken CK, Kaldor JM. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. Med J Aust 1999; 170: 220-221.
4. Crofts N, Thompson SC, Kaldor J. Epidemiology of hepatitis C virus. Technical report series. Communicable Diseases Intelligence. Canberra: Commonwealth Department of Health and Aged Care, 1999.
5. Drug use and prisons. An international perspective. Amsterdam: Harwood Academic Publishers, 2000.
6. Vlahov D, Nelson KE, Quinn TC, et al. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol 1993; 9: 566-569.
7. Ford PM, Pearson M, Sankar-Mistry P, et al. HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Queen's University HIV Prison Study Group. QJM 2000; 93: 113-119.
8. Crofts N, Stewart T, Hearne P, et al. Spread of blood borne viruses among Australian prison entrants. BMJ 1995; 310: 285-288.
9. Butler TG, Dolan KA, Ferson MJ, et al. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust 1997; 166: 127-130.
10. Awofeso N, Harper SE, Levy MH. Prevalence of exposure to hepatitis C virus among prison inmates, 1999. Med J Aust 2000; 172: 94.
11. Crofts N, Thompson S, Wale E, Hernberger F. Risk behaviours for blood-borne viruses in a Victorian prison. ANZ J Crim 1996; 29: 20-28.
12. Levy MH. Australian prisons are still health risks. Med J Aust 1999; 171: 7.
13. Allwright S, Bradley F, Long J, et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ 2000; 321: 78-82.
14. Long J, Allwright S, Barry J, et al. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. BMJ 2001; 323: 1209-1213.
15. Samuel MC, Doherty PM, Bulterys M, et al. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico. Epidemiol Infect 2001; 127: 475-484.
16. Stark K, Bienzle U, Vonk R, et al. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol 1997; 26: 1359-1366.
17. Parker SP, Cubitt WD, Ades AE. A method for the detecting and confirmation of antibodies to hepatitis C virus in dried blood spots. J Virol Meth 1997; 68: 199-205.
18. Statistical profile: The Victorian prison system. Melbourne: Office of the Correctional Services Commissioner, 2001.
19. Buavirat A, Page-Shafer K, van Griensven GJP, et al. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ 2003; 326: 308-310.
20. Post JJ, Dolan KA, Whybin LR, et al. Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route. Med J Aust 2001; 174: 183-184.
21. Christensen PB, Krarup HB, Niesters HGM, et al. Prevalence and incidence of blood borne viral infections among Danish prisoners. Eur J Epidemiol 2000; 16: 1043-1049.
22. Dolan K, Wodak A, Hall W, et al. HIV risk behaviour of IDUs before, during and after imprisonment in New South Wales. Addiction Research 1996; 4: 151-160.
23. Stark K, Muller R, Wirth D, et al. Determinants of HIV infection and recent risk behaviour among injecting drug users in Berlin by site of recruitment. Addiction 1995; 90: 1367-1375.
24. Health Outcomes International Pty Ltd in Association with The National Centre for HIV Epidemiology and Clinical Research and Professor Michael Drummond, York University for the Australian Department of Health and Ageing. Return on investment in needle and syringe programs in Australia; October 2002.
25. Veit F. A report on the study of syringe exchanges in European prisons. Melbourne: Burnet Institute/The Winston Churchill Memorial Trust of Australia, 2001.
26. Rutter S, Dolan K, Wodak A, et al. Prison-based syringe exchange programs. A review of international research and program development. Sydney: National Drug and Alcohol Research Centre, 2001.